Search fresh public links, source activity, and post angles for Advertising And Promotion (Opdp).
Fresh curated links around Advertising and Promotion (OPDP) are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
By Charles D. Snow & Dara Katcher Levy —
FDA released its FY 2027 congressional justification last week. The $7.2 billion topline is less interesting than what's underneath it—the budget translates this administration's p...
In Advisory Opinion 25-11 issued December 15, 2025, the Department of Health and Human Services Office of Inspector General (OIG) offers important and practical guidance for pharma...
Regulatory Overview: Post-Approval Changes to Marketed Drugs - The popularity of GLP-1s have brought post-approval changes to New Drug Applications (NDAs) to centerstage. Recently...
The popularity of GLP-1s have brought post-approval changes to New Drug Applications (NDAs) to centerstage. Recently, the FDA approved Wegovy in tablet form, offering an alternativ...
The GLP-1 market is set to hit over $30 billion by 2030. Intellectual property litigation and FDA crackdowns have led to a boom in M&A and partnership activity. Long-term pat...
The campaign, titled “We Know Now,” was launched in mid-2025 following the introduction of Lilly’s GLP-1 drug Mounjaro for obesity and diabetes.
On today’s episode of AD Nauseam, Amy and Daniel explore substantiation for cosmetic advertising claims, outlining how companies can effectively promote beauty products without cro...
TREVOSE, Pa., May 8, 2026 /PRNewswire/ -- Promotional products outrank television and digital (including internet, mobile and social media) as consumers' most preferred advertising...
The Federal Trade Commission, along with a coalition of states, has taken decisive action to stop alleged collusion between the nation’s largest advertising agencies that purported...
Building on a 6x increase in revenue over the past three years, GPOPlus+ is now targeting the 5 to 35 store chain segment and advancing its data-driven growth strategy at the NACS...
By Fabiola C. Gomez, Ph.D., CMC Regulatory Expert —
When the FDA Says “No” After Saying “Yes”: What the RP1 Decision Gets Wrong Anonymous (not verified) Wed, 04/22/2026 - 11:12 pharmagather item url When the...
By Charles D. Snow & Karla L. Palmer —
The U.S. Food and Drug Administration (FDA) announced on April 13, 2026, that it sent reminder letters to more than 2,200 drug, biologic, and medical device companies and researche...
The DTI is in hot water anew after proposing that businesses are required to secure a permit before publishing any ads and promos online. This was opposed by Senator Bam Aquino, ex...
On May 8, 2026, the U.S. Food and Drug Administration (FDA) issued final guidance describing how the Agency intends to prioritize enforcement for certain unauthorized electronic ni...
With spring conference season underway, April has been a month of growth and connection. Our team has been active—hosting and attending industry events, engaging with clients, and...
With spring conference season underway, April has been a month of growth and connection. Our team has been active—hosting and attending industry events, engaging with clients, and...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.